Annovis Bio, Inc.
ANVS
$2.37
-$0.01-0.42%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -12.72% | -26.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.18% | -6.71% | |||
| Operating Income | 0.18% | 6.71% | |||
| Income Before Tax | -12.33% | 5.59% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.33% | 5.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.33% | 5.59% | |||
| EBIT | 0.18% | 6.71% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -0.47% | 25.26% | |||
| Normalized Basic EPS | -0.50% | 25.29% | |||
| EPS Diluted | 0.00% | 33.03% | |||
| Normalized Diluted EPS | -0.50% | 25.29% | |||
| Average Basic Shares Outstanding | 11.79% | 26.36% | |||
| Average Diluted Shares Outstanding | 11.79% | 26.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||